{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:07:00Z","timestamp":1791313620905,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health System Research Institute","doi-asserted-by":"publisher","award":["HSRI 64\\u2013082"],"award-info":[{"award-number":["HSRI 64\\u2013082"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","award":["621H219"],"award-info":[{"award-number":["621H219"]}],"id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","award":["IN64111"],"award-info":[{"award-number":["IN64111"]}],"id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015396","name":"Thailand Center of Excellence for Life Sciences","doi-asserted-by":"publisher","award":["TC-12\/63"],"award-info":[{"award-number":["TC-12\/63"]}],"id":[{"id":"10.13039\/100015396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.dmpk.2021.100436","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:32:21Z","timestamp":1638567141000},"page":"100436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine"],"prefix":"10.1016","volume":"43","author":[{"given":"Kanyarat","family":"Khaeso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharee","family":"Komvilaisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-5626","authenticated-orcid":false,"given":"Su-on","family":"Chainansamit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-3178","authenticated-orcid":false,"given":"Nontaya","family":"Nakkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunanya","family":"Suwannaying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchayanan","family":"Kuwatjanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-2401","authenticated-orcid":false,"given":"Keiko","family":"Hikino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areerat","family":"Dornsena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirimas","family":"Kanjanawart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napat","family":"Laoaroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suda","family":"Vannaprasaht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6722-8796","authenticated-orcid":false,"given":"Wichittra","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.dmpk.2021.100436_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/dmd.118.081844","article-title":"Three faces of mercaptopurine cytotoxicity in\u00a0vitro: methylation, nucleotide homeostasis, and deoxythioguanosine in DNA","volume":"46","author":"Coulthard","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1987.4","article-title":"Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations","volume":"41","author":"Lennard","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2125.2004.02112.x","article-title":"Thiopurine S-methyltransferase genetic polymorphism in the Thai population","volume":"58","author":"Srimartpirom","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.leu.2401723","article-title":"Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia","volume":"14","author":"McLeod","year":"2000","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.dmpk.2021.100436_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A\u00a0common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.dmpk.2021.100436_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.dmpk.2021.100436_bib9","series-title":"NUDT15","author":"The Pharmacogene Variation Consortium","year":"2020"},{"issue":"5","key":"10.1016\/j.dmpk.2021.100436_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/FPC.0000000000000274","article-title":"NUDT15 genotype distributions in the Korean population","volume":"27","author":"Kim","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.dmpk.2021.100436_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5217\/ir.2017.15.3.328","article-title":"NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases","volume":"15","author":"Sato","year":"2017","journal-title":"Intest. Res."},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/pgs-2017-0147","article-title":"Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients","volume":"19","author":"Sutiman","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.dmpk.2021.100436_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/tpj.2017.12","article-title":"Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia","volume":"18","author":"Tanaka","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"9","key":"10.1016\/j.dmpk.2021.100436_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/MIB.0000000000001148","article-title":"Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multicenter analysis","volume":"23","author":"Chao","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib15","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.3324\/haematol.2015.134775","article-title":"NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia","volume":"101","author":"Chiengthong","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.13518","article-title":"Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia","volume":"171","author":"Tanaka","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.dmpk.2021.100436_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":"Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.dmpk.2021.100436_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-008-2307-1","article-title":"Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine\/6-mercaptopurine treatment","volume":"44","author":"Uchiyama","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"issue":"11","key":"10.1016\/j.dmpk.2021.100436_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s100380200095","article-title":"DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency","volume":"47","author":"Cao","year":"2002","journal-title":"J\u00a0Hum Genet"},{"issue":"10","key":"10.1016\/j.dmpk.2021.100436_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10038-004-0183-y","article-title":"Distribution of ITPA P32T alleles in multiple world populations","volume":"49","author":"Marsh","year":"2004","journal-title":"J\u00a0Hum Genet"},{"issue":"13","key":"10.1016\/j.dmpk.2021.100436_bib21","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-07-6790","article-title":"Transporter-mediated protection against thiopurine-induced hematopoietic toxicity","volume":"68","author":"Krishnamurthy","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.dmpk.2021.100436_bib22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00535-010-0248-y","article-title":"The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease","volume":"45","author":"Ban","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/tpj.2014.74","article-title":"Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia","volume":"15","author":"Tanaka","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"10.1016\/j.dmpk.2021.100436_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00535-017-1416-0","article-title":"Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping","volume":"53","author":"Kakuta","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.dmpk.2021.100436_bib25","series-title":"National protocol for the treatment of childhood cancers 2016","author":"Thai Pediatric Oncology Group","year":"2016"},{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann Hum Genet"},{"issue":"12","key":"10.1016\/j.dmpk.2021.100436_bib27","first-page":"2710","article-title":"Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms","volume":"32","author":"Tsujimoto","year":"2018"},{"issue":"8","key":"10.1016\/j.dmpk.2021.100436_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/ped.13905","article-title":"Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia","volume":"61","author":"Buaboonnam","year":"2019","journal-title":"Pediatr Int"},{"issue":"11","key":"10.1016\/j.dmpk.2021.100436_bib29","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.7314\/APJCP.2015.16.11.4609","article-title":"Outcome of childhood acute lymphoblastic leukemia treated using the Thai National protocols","volume":"16","author":"Seksarn","year":"2015","journal-title":"Asian. Pac. J. Cancer. Prev. APJCP"},{"issue":"7","key":"10.1016\/j.dmpk.2021.100436_bib30","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/bcp.13943","article-title":"Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia","volume":"85","author":"Choi","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.dmpk.2021.100436_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0000000000000282","article-title":"The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia","volume":"27","author":"Moriyama","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.dmpk.2021.100436_bib32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4143\/crt.2017.283","article-title":"NUDT15 variants cause hematopoietic toxicity with low 6-TGN levels in children with acute lymphoblastic leukemia","volume":"50","author":"Yi","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.dmpk.2021.100436_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fphar.2019.00654","article-title":"Star allele-based haplotyping versus gene-wise variant burden scoring for predicting 6-mercaptopurine intolerance in pediatric acute lymphoblastic leukemia patients","volume":"10","author":"Park","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100436_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-018-0190-1","article-title":"Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms","author":"Tsujimoto","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.dmpk.2021.100436_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14258","article-title":"Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia","author":"Zhou","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2021.100436_bib36","first-page":"4552","article-title":"Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.dmpk.2021.100436_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.leukres.2011.11.015","article-title":"The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children","volume":"36","author":"Tanaka","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.dmpk.2021.100436_bib38","first-page":"1","article-title":"ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in Chinese patients with acute lymphoblastic leukemia","author":"Fan","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.dmpk.2021.100436_bib39","first-page":"199","article-title":"TPMT genetic variability and its association with hematotoxicity in Indonesian children with acute lymphoblastic leukemia in maintenance therapy","volume":"14","author":"Rosdiana","year":"2021","journal-title":"Pharmgenomics Pers. Med."},{"issue":"6","key":"10.1016\/j.dmpk.2021.100436_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/pgs-2019-0177","article-title":"NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia","volume":"21","author":"Puangpetch","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12885-018-4398-2","article-title":"Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?","volume":"18","author":"Zhou","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.dmpk.2021.100436_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2710.2011.01272.x","article-title":"Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine","volume":"37","author":"Wan Rosalina","year":"2012","journal-title":"J.\u00a0Clin. Pharm. Therapeut."},{"key":"10.1016\/j.dmpk.2021.100436_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2407-14-299","article-title":"Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia","volume":"14","author":"Farfan","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.dmpk.2021.100436_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00280-018-3732-3","article-title":"Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia","volume":"83","author":"Khera","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.dmpk.2021.100436_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fphar.2019.00916","article-title":"ITPA, TPMT, and NUDT15 genetic polymorphisms predict 6-mercaptopurine toxicity in Middle Eastern children with acute lymphoblastic leukemia","volume":"10","author":"Moradveisi","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2021.100436_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41390-020-0868-8","article-title":"Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants","volume":"89","author":"Wang","year":"2021","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.dmpk.2021.100436_bib47","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmpk.2021.100436_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/08880019109028803","article-title":"Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia","volume":"8","author":"Schmiegelow","year":"1991","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.dmpk.2021.100436_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaoncol.2015.0245","article-title":"Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: a children's oncology group study","volume":"1","author":"Bhatia","year":"2015","journal-title":"JAMA Oncol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436721000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436721000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:13:46Z","timestamp":1778800426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436721000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":49,"alternative-id":["S1347436721000574"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2021.100436","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2021.100436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100436"}}